Oxiracetam prevented the scopolamine but not the diazepam induced memory deficits in mice
Language English Country Netherlands Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
12110475
DOI
10.1016/s0166-4328(02)00028-1
PII: S0166432802000281
Knihovny.cz E-resources
- MeSH
- Muscarinic Antagonists pharmacology MeSH
- Maze Learning drug effects MeSH
- Diazepam pharmacology MeSH
- GABA Modulators pharmacology MeSH
- Mice MeSH
- Nootropic Agents pharmacology MeSH
- Memory Disorders chemically induced prevention & control MeSH
- Transfer, Psychology drug effects MeSH
- Pyrrolidines pharmacology MeSH
- Scopolamine antagonists & inhibitors pharmacology MeSH
- Anxiety psychology MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Muscarinic Antagonists MeSH
- Diazepam MeSH
- GABA Modulators MeSH
- Nootropic Agents MeSH
- oxiracetam MeSH Browser
- Pyrrolidines MeSH
- Scopolamine MeSH
In mice, the elevated plus-maze paradigm was used to investigate the effect of scopolamine hydrobromide and diazepam and their interaction with oxiracetam on the retrieval of spatial memory trace. This paradigm measures (using the transfer latency) an animal's capacity to escape from the open arm to the enclosed one. The retention session followed 24 h after the acquisition one. Experiment 1: Scopolamine (0.25 and 0.5 mg/kg) and diazepam (0.5 and 1.0 mg/kg) given 30 min before the retention session significantly prolonged the transfer latency as compared with the saline treated mice and those given the lowest dose of scopolamine (0.125 mg/kg) and diazepam (0.25 mg/kg). Experiment 2: Oxiracetam administered at doses of 3, 10 and 30 mg/kg immediately after the acquisition session prevented the scopolamine induced prolongation of the transfer latency. Thus, oxiracetam forestalled the impairment of retrieval of memory trace: the animals were able to remember the spatial configuration of the plus-maze. On the contrary, oxiracetam was not effective in the diazepam treated mice. We suggest that beneficial effect of oxiracetam might be confounded or blocked by the anxiolytic effect of diazepam.
References provided by Crossref.org